THE COOPER COMPANIES, INC. The Cooper Companies, Inc. Share Price Deutsche Boerse AG
Equities
CP60
US2166485019
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 82.35 EUR | -1.08% |
|
-2.41% | -3.12% |
| Sales 2024 * | 3.89B 3.64B 325B | Sales 2025 * | 4.15B 3.88B 347B | Capitalization | 17.76B 16.63B 1,484B |
|---|---|---|---|---|---|
| Net income 2024 * | 452M 423M 37.75B | Net income 2025 * | 601M 563M 50.2B | EV / Sales 2024 * | 5.16 x |
| Net Debt 2024 * | 2.28B 2.13B 190B | Net Debt 2025 * | 1.76B 1.65B 147B | EV / Sales 2025 * | 4.71 x |
| P/E ratio 2024 * |
41
x | P/E ratio 2025 * |
29.1
x | Employees | 15,000 |
| Yield 2024 * |
0.07% | Yield 2025 * |
0.07% | Free-Float | 91.34% |
More Fundamentals
* Assessed data
More news
Latest transcript on The Cooper Companies, Inc.
More recommendations
More press releases
More news
| 1 day | -1.08% | ||
| 1 week | -2.41% | ||
| Current month | -1.31% | ||
| 1 month | -4.76% | ||
| 3 months | -10.42% | ||
| 6 months | -2.84% | ||
| Current year | -3.12% |
1 week
82.95
85.25
1 month
82.9587.95
Current year
80.0094.30
1 year
72.7594.30
3 years
63.8597.10
5 years
55.0097.10
10 years
24.7197.10
| Managers | Title | Age | Since |
|---|---|---|---|
Albert White
CEO | Chief Executive Officer | 54 | 01/06/01 |
Robert Weiss
CHM | Chairman | 77 | 01/77/01 |
Brian Andrews
DFI | Director of Finance/CFO | 45 | 01/06/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Teresa Madden
BRD | Director/Board Member | 67 | 01/20/01 |
Lawrence Kurzius
BRD | Director/Board Member | 66 | 01/12 |
William Kozy
BRD | Director/Board Member | 72 | 01/16/01 |
| Date | Price | Change |
|---|---|---|
| 26/24/26 | 82.95 | -0.36% |
| 25/24/25 | 83.25 | -2.23% |
| 24/24/24 | 85.15 | -0.12% |
| 21/24/21 | 85.25 | +0.24% |
| 20/24/20 | 85.05 | +0.06% |
Delayed Quote Deutsche Boerse AG, June 26, 2024 at 11:40 am IST
More quotes
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVisionâs products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and womenâs health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within womenâs health. CooperSurgicalâs brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Calendar
29/08/2024
- Q3 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
89.21
USD
Average target price
109.7
USD
Spread / Average Target
+22.99%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.09% | 44.27B | |
| -27.37% | 1.93B | |
| +11.91% | 1.87B | |
| +21.69% | 1.16B | |
| +75.35% | 659M | |
| -9.57% | 634M | |
| -44.04% | 633M | |
| -45.65% | 604M | |
| +31.34% | 551M |
- Stock Market
- Equities
- COO Stock
- CP60 Stock
